The global Contract Development and Manufacturing Organization (CDMO) market growth continues to attract significant analyst attention, with leading research firms providing varying estimates based on different methodological approaches and scope definitions.
While individual forecasts range considerably—from conservative manufacturing-focused projections to comprehensive outsourcing market assessments—a composite analysis reveals underlying market consensus.
Composite CDMO Market Estimate
Based on analysis of major research publications, we estimate the 2025 global CDMO market at approximately $220 billion USD, rising to $236 Billion in 2026, with projections reaching $420 billion by 2032-2034. This composite average accounts for definitional differences between sources.
The 7.5% compound annual growth rate (CAGR) consensus reflects industry fundamentals including increased pharmaceutical outsourcing, patent cliff opportunities, and biologics market expansion, despite short-term capacity constraints and geopolitical supply chain pressures.
Market Forecasts by Source
Fortune Business Insights
- 2024: $238.92 billion Source
- 2025: $255.01 billion
- 2032: $465.24 billion
- CAGR: 9.0% (2025-2032)
Mordor Intelligence
- 2025: $258.88 billion Source
- 2030: $353.20 billion
- CAGR: 6.41% (2025-2030)
- Scope: Core pharmaceutical CDMO services with focus on API manufacturing (55.44% market share)
Precedence Research
- 2024: $184.90 billion Source
- 2025: $197.40 billion
- 2034: $368.70 billion
- CAGR: 7.2% (2024-2034)
Grand View Research (Pharmaceutical CDMO)
- 2023: $146.00 billion Source
- 2030: $235.50 billion
- CAGR: 7.2% (2024-2030)
